Transaction Date | Company Name | Insider Name (Title) | Activity | Stock | Acquired or Disposed | Shares | Price range | Amount |
---|---|---|---|---|---|---|---|---|
2024-10-14 | Century Therapeutics, Inc. | Conn Morgan
(Chief Finanical Officer) |
A | Common Stock | A | 60148 | $0.00 - $0.00 | $0 |
2024-10-01 | Century Therapeutics, Inc. | Cowan Chad
(Chief Scientific Officer) |
A | Common Stock | A | 74376 | $0.00 - $0.00 | $0 |
2024-09-12 | Century Therapeutics, Inc. | Quimi Daphne
(Director) |
P | Common Stock | A | 5000 | $1.53 - $1.53 | $7,657 |
2024-08-05 | Century Therapeutics, Inc. | Farid Adrienne
(Chief Operations Officer) |
S | Common Stock | D | 1073 | $1.83 - $1.83 | $1,960 |
2024-08-05 | Century Therapeutics, Inc. | Carr Douglas
(SVP Finance & Operations) |
S | Common Stock | D | 289 | $1.83 - $1.83 | $528 |
2024-07-26 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
S | Common Stock | D | 586 | $2.50 - $2.50 | $1,465 |
2024-07-23 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
S | Common Stock | D | 1800 | $2.50 - $2.52 | $4,529 |
2024-06-20 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
S | Common Stock | D | 5000 | $2.84 - $2.84 | $14,178 |
2024-06-07 | Century Therapeutics, Inc. | Carr Douglas
(SVP Finance & Operations) |
A | Common Stock | A | 17007 | $0.00 - $0.00 | $0 |
2024-06-05 | Century Therapeutics, Inc. | Russotti Gregory
(See Remarks) |
S | Common Stock | D | 5000 | $3.00 - $3.00 | $14,988 |
A | Grant, award or other acquisition |
C | Conversion of Derivative or Security |
D | Disposition to the issuer of issuer equity securities |
E | Expiration of short derivative position |
F | Payment of exercise price or tax liability |
G | Bona fide Gift |
H | Expiration (or cancellation) of long derivative position with value received |
I | Discretionary Transaction |
J | Other acquisition or disposition |
K | Transaction in equity swap or instrument with similar characteristics |
L | Small Acquisition |
M | Exercise or conversion of derivative security |
O | Exercise of out-of-the-money derivative security |
P | Open Market Purchase |
S | Open Market Sale |
U | Disposition pursuant to a tender of shares in a change of control transaction |
V | Transaction Voluntarily Reported |
X | Exercise of in-the-money or at-the-money derivative security |
Z | Deposit into or withdrawal from voting trust |